Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

EC approves Herceptin for stomach cancer

January 29, 2010 1:05 AM UTC

The EC approved an expanded label for Herceptin trastuzumab from Roche (SIX:ROG; OTCQX:RHHBY) to include treatment of advanced HER2-positive stomach cancer. The humanized mAb against human EGFR-2 ( HER2) is already approved for HER2-positive breast cancer. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article